Related Experiment Videos

Cardiovascular Safety Across Leading BTK Inhibitors in Relapsed/Refractory CLL: Results of a Network Meta-Analysis

Stefano Molica1, Diana Giannarelli2, David Allsup3

  • 1Hull York Medical School, University of Hull, Hull, UK.

European Journal of Haematology
|May 8, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...